Figure 3.
Genome-wide CRISPR knock-out Srsf2P95H/+ screen. (A) Schematic outline of the pooled CRISPR knock-out Srsf2 screen. (B) Visualization of performance of sgRNA against genes mutated in MDS and MDS/myeloproliferative neoplasm at day 18 of the screen. Gray dots, all the sgRNA identified; red dots, sgRNA with FDR < .01 and β score <−2.

Genome-wide CRISPR knock-out Srsf2P95H/+ screen. (A) Schematic outline of the pooled CRISPR knock-out Srsf2 screen. (B) Visualization of performance of sgRNA against genes mutated in MDS and MDS/myeloproliferative neoplasm at day 18 of the screen. Gray dots, all the sgRNA identified; red dots, sgRNA with FDR < .01 and β score <−2.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal